Gene polymorphisms provide means to obtain unconfounded associations between carotenoids and various health outcomes. We tested whether gene polymophorisms and gene scores linked to serum carotenoid status are related to metabolic disturbance and depressive symptoms in African-American adults residing in Baltimore city, MD, using cross-sectional data from the Healthy Aging in Neighborhood of Diversity Across the Lifespan (HANDLS) study (Age range:30–64y, N=873–994). We examined 24 single nucleotide polymorphisms of various gene loci that were previously shown to be associated with low serum carotenoid status (SNPlcar). Genetic risk scores (5 low specific-carotenoid risk scores (LSCRS: α-carotene, β-carotene, lutein+zeaxanthin, β-cryptoxanthin, lycopene) and 1 low total-carotenoid risk score (LTCRS: total carotenoids)) were created. SNPlcar, LSCRS and LTCRS were entered as predictors for a number of health outcomes. Those included obesity, National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III metabolic syndrome (MetS) and its components, elevated homeostatic model assessment, Insulin Resistance (HOMA-IR), C-reactive protein (CRP), hyperuricemia and elevated depressive symptoms (EDS, Center for Epidemiologic Studies-Depression (CES-D) score≥16). Among key findings, SNPlcar were not associated with the main outcomes after correction for multiple testing. However, an inverse association was found between LTCRS and HDL-C dyslipidemia. Specifically, the α-carotene and β-cryptoxanthin LSCRS were associated with lower odds of HDL-C dyslipidemia. However, the β-cryptoxanthin LSCRS was linked to a higher odds of EDS, with a linear dose-response relationship. In sum, gene risk scores linked to low serum carotenoids had mixed effects on HDL-C dyslipidemia and EDS. Further studies using larger African-American samples are needed.